angiotensin ii has been researched along with Cardiac Diseases in 145 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (13.79) | 18.7374 |
| 1990's | 15 (10.34) | 18.2507 |
| 2000's | 37 (25.52) | 29.6817 |
| 2010's | 57 (39.31) | 24.3611 |
| 2020's | 16 (11.03) | 2.80 |
| Authors | Studies |
|---|---|
| Hua, D; Li, P; Li, Y; Mao, Y; Wu, X; Yong, Y; Zhao, K; Zhou, Z | 1 |
| Han, C; Hu, L; Huang, R; Huang, Y; Li, J; Lin, H; Ooi, K; Qian, X; Ren, X; Xia, C; Zhang, S | 1 |
| Chen, PH; Chen, YJ; Chung, CC; Kao, YH; Liu, SH | 1 |
| Chlebowski, MM; Goldstein, SL; Kim, ME | 1 |
| Jiao, X; Lei, Z; Li, D; Wang, J; Xing, D; Zhang, Y | 1 |
| Malunga, L; Netticadan, T; Raj, P; Sabra, A; Sayfee, K; Thandapilly, SJ; Wijekoon, C; Yu, L | 1 |
| Gu, L; Li, Y; Shi, H; Sun, J; Wang, H; Wang, L; Wang, Q; Wang, S; Wang, Z; Wei, T | 1 |
| Awwad, ZM; El-Ganainy, SO; El-Khatib, AS; ElMallah, AI; Khattab, MM; Khedr, SM | 1 |
| Ding, L; Lu, Q; Lu, S; Lyu, D; Ma, Z; Ouyang, C; Zhou, Y | 1 |
| Han, F; Jin, D | 1 |
| Ahn, Y; Al-Harthy, SD; Asano, S; Boucher, M; Chen, X; Cunio, T; Hales, K; Kreuser, S; LaViolette, B; Nagle, MW; Pang, J; Ritenour, C; Robertson, A; Roth Flach, RJ; Sessa, WC; Shipstone, A; Sobon, H; Song, L; Sun, F; Swanson, TA; Voigt, F | 1 |
| Badrealam, KF; Ho, TJ; Hsuan Day, C; Huang, CY; Kuo, WW; Lai, PF; Lin, YM; Shao-Tsu Chen, W; Shibu, MA; Viswanadha, VP | 1 |
| Bai, N; Li, G; Li, J; Li, L; Li, T; Li, W; Liu, G; Lou, Q; Wang, Y; Yang, W; Zhan, C; Zhang, L; Zhao, H; Zheng, M | 1 |
| Krishnan, S; Li, J; Mohandas, R; Raizada, MK; Richards, EM; Sharma, RK | 1 |
| Chao, ML; Chen, JY; Huang, ZR; Ji, Y; Luo, SS; Shi, ZG; Sun, SX; Xie, LP; Zhang, C; Zhou, M; Zhou, XC | 1 |
| Fang, H; Li, L; Liu, SX; Yang, ZQ; Yu, YH | 1 |
| Cohen, IS; Jiang, YP; Kim, JH; Lin, RZ; Mathias, RT | 1 |
| Choi, SY; Kim, CR; Kim, MH; Park, JS; Roh, MS; Serebruany, V | 1 |
| Bhattacharya, SK; Chen, Y; Lu, L; Sun, Y; Zhao, T; Zhao, W | 1 |
| Bunrukchai, K; Mangmool, S; Parichatikanond, W; Phosri, S; Sato, VH | 1 |
| Cai, Y; Huang, B; Huang, J; Liu, X; Wu, B; Xiao, Y; Ye, J; Zhang, G; Zhou, Y; Zhu, L | 1 |
| Han, QH; James, E; McKallip, RJ; Qin, DZ; Wang, NP; Yang, LW; Zhang, WW; Zhao, ZQ; Zheng, RH | 1 |
| Bartolomucci, A; Beker, DL; Dyck, JRB; Grant, MK; Hamza, SM; Matsumura, N; Parajuli, N; Razzoli, M; Robertson, IM; Soltys, CM; Zordoky, BN | 1 |
| McCarthy, CG; Wenceslau, CF | 1 |
| Booz, GW; Coffman, TM; Eguchi, S; Forrester, SJ; Kawai, T; Rizzo, V; Scalia, R; Sigmund, CD | 1 |
| Chen, X; Lin, Y; Luo, W; Shi, Y; Song, A; Wang, W; Zeng, Y; Zhang, Y | 1 |
| Chen, G; Chen, RR; Fan, XH; Liu, XT; Wang, CY; Xue, YG; Zeng, GW | 1 |
| Cao, L; Chen, YL; Fan, J; Han, TL; Ling, Z; Xu, Y; Yin, Y; Zeng, M | 1 |
| Abraham, D; Acar, E; Costantino, S; Gonçalves, IF; Hallström, S; Hamza, O; Kiss, A; Klein, KU; Paneni, F; Podesser, BK; Szabo, PL; Tretter, EV; Trojanek, S | 1 |
| Alaboodi, SA; Alassiri, M; Aldera, H; Alkhateeb, MA; Alnamar, NM; Eid, RA; El-Kott, AF; Eleawa, SM; Khalil, MA; Salem Al-Shudiefat, AA; Zaki, MSA | 1 |
| Azibani, F; Chatziantoniou, C; Delcayre, C; Fazal, L; Samuel, JL | 1 |
| Delafontaine, P; Galvez, S; Higashi, Y; Mitch, WE; Sukhanov, S; Tabony, AM; Yoshida, T | 1 |
| Chen, S; Guo, J; Jia, Y; Jiang, J; Liu, P; Xu, J; Yu, Y | 1 |
| Cui, W; Du, J; Li, HH; Li, YL; Wang, L; Wang, X; Xia, Y; Zhang, CC | 1 |
| Ahmad, S; Ferrario, CM; Nagata, S; Varagic, J | 1 |
| Basu, R; Fan, D; Kassiri, Z; Oudit, GY; Parajuli, N; Patel, VB; Penninger, JM; Ramprasath, T; Wang, W; Wang, Z | 1 |
| Beck, PL; Bracey, NA; Chun, J; Duff, HJ; Fedak, PW; Gershkovich, B; Meijndert, HC; Muruve, DA; Vilaysane, A; Wright, JR | 1 |
| Du, J; Hui, M; Jia, L; Li, Y; Wang, J; Wang, Y; Wu, Y; Xie, B | 1 |
| Guo, J; Huo, ZJ; Ji, XL; Li, FY; Liu, C; Peng, B; Shen, HB; Zhang, L | 1 |
| Apel, IJ; Balogh, A; Binger, KJ; Choi, M; Dechend, R; Fokuhl, V; Haase, N; Henke, N; Heuser, A; Lucas, PC; Luft, FC; Markó, L; McAllister-Lucas, LM; Müller, DN; Oravecz-Wilson, KI; Park, JK; Przybyl, L; Qadri, F; Ruland, J; Spallek, B; Wilck, N | 1 |
| Crowley, SD | 1 |
| Chen, X; Huang, C; Huang, J; Liu, S; Luo, Y | 1 |
| Bai, D; Gao, Y; Ge, L; Lu, X; Wang, H; Yang, G | 1 |
| Chen, P; Li, X; Luo, J; Patterson, AJ; Xue, Q; Zhang, G | 1 |
| Arumugam, S; Karuppagounder, V; Krishnamurthy, P; Nakamura, M; Sreedhar, R; Suzuki, K; Thandavarayan, RA; Watanabe, K | 1 |
| Conte, D; Minas, JN; Nishiyama, A; Ortiz, RM; Thorwald, MA; Vázquez-Medina, JP | 1 |
| Brdar, M; Dear, AE; Gaspari, T; Hu, Y; Lee, HW; Simpson, RW; Spizzo, I; Widdop, RE | 1 |
| Gaikwad, AB; Goru, SK; Kadakol, A; Malek, V; Pandey, A | 1 |
| Huang, N; Liu, JJ; Lu, Y; Yang, Y; Yang, YH; Yu, XJ; Zang, WJ; Zhao, M | 1 |
| Ahmadian, E; Jafari, S; Yari Khosroushahi, A | 1 |
| Chen, L; Deng, L; Guo, X; Leng, B; Liu, X; Lv, L; Qiao, G; Shan, H; Xu, W; Yao, Z; Zhao, D; Zhou, Y | 1 |
| Duerrschmid, C; Entman, ML; Haudek, SB; Mayr, M; Medrano, G; Taffet, GE; Wang, Y | 1 |
| Anagnostopoulou, A; De Lucca Camargo, L; Montezano, AC; Touyz, RM | 1 |
| Carretero, OA; D'Ambrosio, MA; Liao, TD; Lin, CX; Rhaleb, NE; Yang, XP | 1 |
| Wu, R; Zeng, Y | 1 |
| Brown, NJ; Fogo, AB; Fowler, SM; Kwak, ES; Lea, WB; Luther, JM; Ma, J; Wang, Z | 1 |
| Dechend, R; Elitok, S; Fischer, R; Gratze, P; Kleinewietfeld, M; Kvakan, H; Luft, FC; Muller, DN; Park, JK; Plehm, R; Qadri, F; Rahn, HP; Schwarz, I; Wellner, M | 1 |
| Bandyopadhyay, A; Bandyopadhyay, D; Chander, V; De, P; Konar, A; Mukherjee, D; Roy, SG | 1 |
| Darbar, D; Donahue, BS; Ellinor, PT; Kaiser, DW; Kannankeril, PJ; MacRae, CA; Makino, S; Roden, DM; Wasserman, BS; Watanabe, H | 1 |
| Anegawa, T; Hirooka, Y; Ikeda, A; Imaizumi, T; Kai, H; Kajimoto, H; Kato, S; Koga, M; Kudo, H; Mifune, H; Mori, T; Takayama, N; Yasuoka, S | 1 |
| Almeida, J; Barreto-Chaves, ML; Carneiro-Ramos, MS; Diniz, GP; Nadu, AP; Santos, RA; Vieira, RL | 1 |
| Kong, XQ; Liu, YL; Wang, LX; Wang, XH; Wang, YL | 1 |
| Leask, A | 1 |
| Fagard, RH; Lijnen, PJ; van Pelt, JF | 1 |
| Chen, R; Eisner, C; Hu, X; Huang, Y; Kopp, JB; Leelahavanichkul, A; Mizel, D; Schnermann, J; Star, RA; Wright, EC; Yan, Q; Yuen, PS; Zhou, H | 1 |
| Dai, Q; Dong, P; Jia, N; Qian, C; Ye, Y | 1 |
| Chen, J; Entman, ML; Lin, SC; Miao, Y; Taffet, GE; Wang, Y; Xu, J | 1 |
| Cordasic, N; Daniel, C; Hartner, A; Heusinger-Ribeiro, J; Hilgers, KF; Klanke, B; Knier, B; Veelken, R | 1 |
| Bombardi, C; Castoldi, G; Catalucci, D; Condorelli, G; Corradi, B; Di Gioia, CR; Gualazzi, MG; Leopizzi, M; Mancini, M; Stella, A; Zerbini, G | 1 |
| Huke, S; Knollmann, BC | 1 |
| Dong, YF; Ichijo, H; Kataoka, K; Kim-Mitsuyama, S; Koibuchi, N; Nako, H; Ogawa, H; Toyama, K; Yamamoto, E; Yasuda, O | 1 |
| Arozal, W; Arumugam, S; Giridharan, VV; Harima, M; Kodama, M; Palaniyandi, SS; Sari, FR; Soetikno, V; Suzuki, K; Thandavarayan, RA; Watanabe, K | 1 |
| Furuta, K; Hongo, M; Ishizaka, N; Nagai, R; Saito, K; Sakamoto, A | 1 |
| Gallagher, PE; McCollum, LT; Tallant, EA | 1 |
| Brown, NJ; Cohen, SE; Fogo, AB; Kim, HS; Luo, P; Luther, JM; Wang, Z | 1 |
| Ardell, JL; Girasole, AE; Hardwick, JC; Negrotto, S; Ryan, SE; Southerland, EM | 1 |
| Brem, AS | 1 |
| Mitsuyama, S | 1 |
| Bezuhly, M; Esmon, CT; Falkenham, AG; Lee, TD; Légaré, JF; Liwski, RS; Rosin, NL; Sopel, MJ | 1 |
| Aiello, EA; De Giusti, VC | 1 |
| Fujita, S; Hiroe, M; Hosotani, N; Imanaka-Yoshida, K; Ishizaka, N; Kitaura, Y; Kohda, Y; Nishioka, T; Otsuka, K; Shimojo, N; Tanaka, T; Terasaki, F; Yoshida, T | 1 |
| Dell'Italia, LJ; Husain, A | 1 |
| Aebi, JD; Blum-Kaelin, D; Dechend, R; Dehmlow, H; Fiebeler, A; Haller, H; Löffler, BM; Luft, FC; Masur, S; Mullally, A; Muller, DN; Park, JK; Pilz, B | 1 |
| Moskowitz, DW | 1 |
| Unger, T; Zimmermann, M | 1 |
| Al-Saadi, N; Dechend, R; Fiebeler, A; Hilfenhaus, G; Jeng, AY; Luft, FC; Maser-Gluth, C; Meiners, S; Muller, DN; Nussberger, J; Rong, S; Shagdarsuren, E; Webb, RL; Wellner, M | 1 |
| Guimarães, S; Pinheiro, H | 1 |
| Sun, Y; Weber, KT | 1 |
| Jin, D; Miyazaki, M; Muramatsu, M; Takai, S | 1 |
| Lim, H; Zhu, YZ | 1 |
| Aries, A; Dali-Youcef, N; Nemer, M; Paradis, P; Wang, H | 1 |
| Hasegawa, K; Hayashi, K; Homma, K; Itoh, H; Kimoto, M; Sugano, N; Tatematsu, S; Wakino, S; Yoshioka, K | 1 |
| Boyle, AJ; Connelly, KA; Kelly, DJ | 1 |
| Burrell, LM; Dean, RG | 1 |
| Müller, DN | 1 |
| Fujita, K; Funahashi, T; Hibuse, T; Hiuge, A; Kihara, S; Kurata, A; Maeda, N; Nishida, M; Nishizawa, H; Ohashi, K; Shimomura, I; Sonoda, M | 1 |
| Anderson, ME; Aykin-Burns, N; Bartlett, RK; Colbran, RJ; Erickson, JR; Guan, X; Ham, AJ; Joiner, ML; Kutschke, W; Lowe, JS; Mohler, PJ; O'Donnell, SE; Oddis, CV; Shea, MA; Spitz, DR; Weiss, RM; Yang, J; Zimmerman, K; Zimmerman, MC | 1 |
| Chan, W; Espiner, EA; Ikram, H; Nicholls, MG | 1 |
| Husain, A; Liao, Y | 1 |
| Hashimoto, K; Horikoshi, S; Kurosawa, H; Miyamoto, H; Suzuki, K | 1 |
| Perryman, MB; Raynolds, MV | 1 |
| De Mello, WC | 1 |
| Abe, K; Kanazawa, M; Kohzuki, M; Sato, T; Yasujima, M; Yoshida, K | 1 |
| Davis, GK; Roberts, DH | 1 |
| Brilla, CG; Funck, RC; Rupp, H; Wilke, A | 1 |
| Musch, TI; Stebbins, CL; Symons, JD | 1 |
| Luft, FC | 1 |
| Colson, P; Coriat, P; Ryckwaert, F | 1 |
| Díez, J; Fortuño, MA; Ravassa, S | 1 |
| Coca, A; Giner, V | 1 |
| Bieringer, M; Breu, V; Dechend, R; Fiebeler, A; Ganten, D; Haller, H; Luft, FC; Mervaala, E; Müller, DN; Park, JK; Schmidt, F | 1 |
| Danser, AH; De Mello, WC | 1 |
| Ferrario, CM; Flack, JM; Mensah, GA | 1 |
| Caridi, G; Ghiggeri, GM; Gusmano, R; Musante, L; Oleggini, R; Ravazzolo, R | 1 |
| Mascareno, E; Siddiqui, MA | 1 |
| Filippatos, G; Pinillos, H; Tilak, M; Uhal, BD | 1 |
| Breu, V; Dechend, R; Dietz, R; Elger, M; Fiebeler, A; Ganten, D; Haller, H; Hampich, F; Heissmeyer, V; Luft, FC; Muller, DN; Park, JK; Pilz, B; Scheidereit, C; Schroer, K; Shagdarsuren, E; Theuer, J | 1 |
| Campbell, DJ; Dixon, B; Kemme, M; Kladis, A; Santamaria, JD | 1 |
| Hasebe, N; Jin, YT; Kido, S; Kikuchi, K; Natori, S; Ohta, T; Sato, M; Tsuji, S | 1 |
| Adler, GK; Martinez, DV; Matsumura, M; Ochoa-Maya, M; Oestreicher, E; Rocha, R; Roubsanthisuk, W; Williams, GH | 1 |
| Corvol, P; Plouin, PF | 1 |
| Bernstein, KE | 1 |
| Mann, DL | 1 |
| Alexander, JK; Gaasch, WH; Quinones, MA; Thiel, HG; Waisser, E | 1 |
| Brown, JJ; Gavras, H; Gray, B; Kremer, D; Lever, AF; MacAdam, RF; medina, A; Morton, JJ; Robertson, JI | 1 |
| Mukharliamov, IM; Ryff, IM | 1 |
| Ahmed, SS; Levinson, GE; Regan, TJ; Weisse, AB | 1 |
| Becker, CE; Benowitz, NL | 1 |
| Ahmad, MR; Ahmed, SS; Haider, B; Levinson, GE; Lyons, MM; Oldewurtel, HA; Regan, TJ | 1 |
| Kaplinsky, N; Koffler, M; Waitman, AD | 1 |
| Cash, JM; Coke, JM; Raab, RW | 1 |
| Kinoshita, M; Mitsunami, K; Sakoda, S | 1 |
| Adachi, H; Ikegaya, K; Inagaki, S; Katahira, T; Katsume, H; Kubota, Y; Matsui, S; Nakagawa, M; Nakagawa, T; Sugihara, H | 1 |
| Frank, MJ; Levinson, GE; Moschos, CB; Oldewurtel, HA; Regan, TJ; Weisse, AB | 1 |
| Berkmen, R | 1 |
| Radó, JP; Szabó, T; Szántó, Z; Takó, J | 1 |
| Krayenbühl, H | 1 |
| Burch, GE; Giles, TD | 1 |
| Chiavaro, A; Cosentino, F; Gambelli, G; Saponaro, A; Strano, A | 1 |
| Agnoli, GC; Cariani, A; Farné, F; Gritti, FM; Montini, T | 1 |
| Messini, M | 1 |
| Iio, M | 1 |
| Donoso, R; Ganz, W; Kivowitz, C; Marcus, H; Parmley, WW; Swan, HJ | 1 |
| Horwitz, LD; Mullins, CB; Payne, RM | 1 |
| Cruickshank, JM; Neil-Dwyer, G | 1 |
32 review(s) available for angiotensin ii and Cardiac Diseases
| Article | Year |
|---|---|
Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; COVID-19; Heart Diseases; Humans; Kidney Diseases; Receptors, Virus; Renin-Angiotensin System; SARS-CoV-2 | 2021 |
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.
Topics: Adipocytes; Angiotensin II; Animals; Blood Vessels; Brain; Heart Diseases; Humans; Inflammation; Kidney; Kidney Diseases; Receptors, Angiotensin; Signal Transduction | 2018 |
Aldosterone mediates cardiac fibrosis in the setting of hypertension.
Topics: Aldosterone; Angiotensin II; Animals; Cytochrome P-450 CYP11B2; Fibrosis; Heart Diseases; Humans; Hypertension | 2013 |
Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.
Topics: Angiotensin II; Animals; Cachexia; Heart Diseases; Humans; Molecular Targeted Therapy; Muscle, Skeletal; Muscular Atrophy; Signal Transduction | 2013 |
ACE2: angiotensin II/angiotensin-(1-7) balance in cardiac and renal injury.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Diseases; Heart Diseases; Humans; Hypertension; Kidney Diseases; Peptide Fragments; Peptidyl-Dipeptidase A | 2014 |
Angiotensin receptor blockers: Focus on cardiac and renal injury.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Drug Interactions; Drug Therapy, Combination; Heart; Heart Diseases; Humans; Kidney; Kidney Diseases; Myocardium; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Treatment Outcome | 2016 |
Role of angiotensin II in stem cell therapy of cardiac disease.
Topics: Angiotensin II; Animals; Heart Diseases; Humans; Models, Biological; Renin-Angiotensin System; Stem Cell Transplantation; Stem Cells | 2015 |
Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation.
Topics: Angiotensin II; Animals; Cardiovascular Agents; Connective Tissue Growth Factor; Drug Design; Endothelin-1; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Heart Diseases; Humans; Myocardium; Platelet-Derived Growth Factor; Signal Transduction; Transforming Growth Factor beta | 2010 |
Stimulation of reactive oxygen species and collagen synthesis by angiotensin II in cardiac fibroblasts.
Topics: Angiotensin II; Animals; Collagen; Fibroblasts; Fibrosis; Free Radical Scavengers; Heart Diseases; Humans; Hypertension; Myocardium; NADPH Oxidases; Oxidative Stress; Reactive Oxygen Species; Superoxides | 2012 |
[Role of the renin-angiotensin system in the brain and cardiorenal system].
Topics: Angiotensin II; Animals; Brain Diseases; Cognition Disorders; Endothelium, Vascular; Heart Diseases; Humans; Kidney Diseases; Nitric Oxide Synthase Type III; Oxidative Stress; Renin-Angiotensin System; Stroke; Vascular Diseases | 2012 |
Regulation of the cardiac sodium/bicarbonate cotransporter by angiotensin II: potential Contribution to structural, ionic and electrophysiological myocardial remodelling.
Topics: Angiotensin II; Calcium; Cardiomegaly; Electrophysiological Phenomena; Heart; Heart Diseases; Humans; Sodium; Sodium-Bicarbonate Symporters; Ventricular Remodeling | 2013 |
Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases.
Topics: Angiotensin I; Angiotensin II; Arteriosclerosis; Cardiomegaly; Cardiovascular Diseases; Chymases; Heart Diseases; Heart Failure; Humans; Hypertension; Peptidyl-Dipeptidase A; Serine Endopeptidases | 2002 |
Pathophysiologic implications of angiotensin I-converting enzyme as a mechanosensor: diabetes.
Topics: Aging; Angiotensin II; Animals; Blood Vessels; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Heart Diseases; Humans; Insulin Resistance; Mechanoreceptors; Peptidyl-Dipeptidase A | 2003 |
Functional evidence that in the cardiovascular system AT1 angiotensin II receptors are AT1B prejunctionally and AT1A postjunctionally.
Topics: Angiotensin II; Animals; Cardiovascular System; Gap Junctions; Heart Diseases; Humans; Models, Animal; Muscle, Smooth, Vascular; Norepinephrine; Receptor, Angiotensin, Type 1; Sympathetic Nervous System | 2005 |
Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models.
Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Aortic Aneurysm; Chymases; Fibrosis; Heart Diseases; Humans; Hypertension; Mast Cells; Myocardial Infarction; Neovascularization, Pathologic; Serine Proteinase Inhibitors | 2006 |
Role of transforming growth factor-beta in the progression of heart failure.
Topics: Angiotensin II; Animals; Cardiac Output, Low; Chronic Disease; Disease Progression; Heart Diseases; Humans; Myocardium; Signal Transduction; Transforming Growth Factor beta; Ventricular Remodeling | 2006 |
Angiotensin II and the cardiac complications of diabetes mellitus.
Topics: Angiotensin II; Animals; Diabetes Complications; Diabetes Mellitus; Heart Diseases; Humans; Up-Regulation | 2007 |
ACE2 and diabetic complications.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diabetes Complications; Heart Diseases; Humans; Kidney Diseases; Peptidyl-Dipeptidase A | 2007 |
The chymase-angiotensin system in humans: biochemistry, molecular biology and potential role in cardiovascular diseases.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Chymases; Heart Diseases; Humans; Hypertension; Molecular Biology; Serine Endopeptidases | 1995 |
The role of genetic variants in angiotensin I converting enzyme, angiotensinogen and the angiotensin II type-1 receptor in the pathophysiology of heart muscle disease.
Topics: Angiotensin II; Angiotensinogen; Bradykinin; Cardiac Output, Low; Cardiomegaly; Genetic Variation; Heart Diseases; Humans; Peptidyl-Dipeptidase A; Receptors, Angiotensin; Renin-Angiotensin System | 1995 |
Molecular genetics of the renin-angiotensin system: implications for angiotensin II receptor blockade.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Heart Diseases; Humans; Myocardium; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Receptors, Angiotensin; Renin-Angiotensin System | 1997 |
Regulation and role of myocardial collagen matrix remodeling in hypertensive heart disease.
Topics: Adult; Aldosterone; Angiotensin II; Animals; Cells, Cultured; Collagen; Collagenases; Heart; Heart Diseases; Humans; Hypertension; Matrix Metalloproteinase 1; Myocardium; Renin-Angiotensin System; Transcription, Genetic | 1997 |
Transforming growth factor beta-angiotensin II interaction: implications for cardiac and renal disease.
Topics: Angiotensin II; Heart Diseases; Humans; Kidney Diseases; Models, Biological; Signal Transduction; Transforming Growth Factor beta | 1999 |
Renin angiotensin system antagonists and anesthesia.
Topics: Anesthesia; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Heart Diseases; Hemodynamics; Humans; Hypertension; Kidney; Receptors, Angiotensin; Renin-Angiotensin System | 1999 |
[Apoptosis in hypertensive cardiopathy].
Topics: Adult; Angiotensin II; Animals; Apoptosis; Cardiomyopathies; Heart Diseases; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin-Like Growth Factor I; Middle Aged; Myocardium; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tumor Suppressor Protein p53 | 1999 |
[Antihypertensive advantages of angiotensin II AT1 receptor antagonism].
Topics: Aged; Angiotensin II; Angiotensin Receptor Antagonists; Anti-Arrhythmia Agents; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Clinical Trials as Topic; Heart Diseases; Heart Failure; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 1999 |
Angiotensin II and the heart : on the intracrine renin-angiotensin system.
Topics: Angiotensin II; Animals; Heart; Heart Diseases; Humans; Myocardium; Physical Stimulation; Receptors, Angiotensin; Reference Values; Renin-Angiotensin System | 2000 |
Using angiotensin converting enzyme inhibitors in African-American hypertensives: a new approach to treating hypertension and preventing target-organ damage.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Black People; Dose-Response Relationship, Drug; Female; Heart Diseases; Humans; Hypertension; Kidney Failure, Chronic; Male; United States | 2000 |
The role of Jak/STAT signaling in heart tissue renin-angiotensin system.
Topics: Angiotensin II; Animals; Cardiomegaly; DNA-Binding Proteins; Heart; Heart Diseases; Humans; Myocardium; Protein-Tyrosine Kinases; Signal Transduction; Trans-Activators | 2000 |
Regulation of apoptosis by angiotensin II in the heart and lungs (Review).
Topics: Angiotensin II; Animals; Apoptosis; Endothelium, Vascular; Heart Diseases; Humans; Lung; Lung Diseases; Myocardium; Renin-Angiotensin System | 2001 |
[Angiotensin II receptor blockers: current status and future prospects].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Heart Diseases; Humans; Hypertension; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2002 |
[Etiology and pathogenesis of primary pulmonary hypertension].
Topics: Adolescent; Adult; Age Factors; Angiotensin II; Appetite Depressants; Arteritis; Child; Diagnosis, Differential; Female; Heart Diseases; Hemodynamics; Humans; Hypertension, Pulmonary; Hypoxia; Lung; Male; Middle Aged; Mycobacterium; Pulmonary Artery; Pulmonary Circulation; Sex Factors | 1975 |
1 trial(s) available for angiotensin ii and Cardiac Diseases
| Article | Year |
|---|---|
Challenges in improving prognosis and therapy: the Ongoing Telmisartan Alone and in Combination with Ramipril Global End point Trial programme.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Germany; Heart Diseases; Humans; Hypertension; Prognosis; Ramipril; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk Reduction Behavior; Telmisartan; Treatment Outcome | 2004 |
112 other study(ies) available for angiotensin ii and Cardiac Diseases
| Article | Year |
|---|---|
Ginkgolide A alleviates cardiac remodeling in mice with myocardial infarction via binding to matrix metalloproteinase-9 to attenuate inflammation.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cardiotonic Agents; Fibronectins; Fibrosis; Ginkgolides; Heart Diseases; Inflammation; Lactones; Matrix Metalloproteinase 9; Mice; Myocardial Infarction; Myocytes, Cardiac; Rats; Ventricular Remodeling | 2022 |
Inhibition of cGAS in Paraventricular Nucleus Attenuates Hypertensive Heart Injury Via Regulating Microglial Autophagy.
Topics: Angiotensin II; Animals; Autophagy; DNA, Mitochondrial; Heart Diseases; Heart Injuries; Hypertension; Mice; Microglia; Nucleotidyltransferases; Paraventricular Hypothalamic Nucleus; Sirolimus | 2022 |
Lithium Treatment Improves Cardiac Dysfunction in Rats Deprived of Rapid Eye Movement Sleep.
Topics: Actins; Angiotensin II; Animals; Heart Diseases; Lithium; Lithium Compounds; NF-kappa B; ORAI1 Protein; Rats; Receptor, Angiotensin, Type 1; Sleep Deprivation; Sleep, REM; Transforming Growth Factor beta | 2022 |
Recombinant angiotensin II therapy in a child with cardiac dysfunction and
Topics: Angiotensin II; Candida; Child; Heart Diseases; Hemodynamics; Humans; Sepsis | 2023 |
Angiotensin II type 1a receptor knockout ameliorates high-fat diet-induced cardiac dysfunction by regulating glucose and lipid metabolism.
Topics: Angiotensin II; Animals; Diet, High-Fat; Fatty Acids; Glucose; Heart Diseases; Lipid Metabolism; Lipids; Rats; Receptor, Angiotensin, Type 1 | 2023 |
Oat Beta-Glucan Alone and in Combination with Hydrochlorothiazide Lowers High Blood Pressure in Male but Not Female Spontaneously Hypertensive Rats.
Topics: Angiotensin II; Animals; beta-Glucans; Blood Pressure; Female; Heart Diseases; Hydrochlorothiazide; Hypertension; Male; Norepinephrine; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2023 |
LncRNA FAF inhibits fibrosis induced by angiotensinogen II via the TGFβ1-P-Smad2/3 signalling by targeting FGF9 in cardiac fibroblasts.
Topics: Angiotensin II; Animals; Cell Proliferation; Fibroblast Growth Factor 9; Fibroblasts; Fibrosis; Heart Diseases; Myocardium; Rats, Sprague-Dawley; RNA, Long Noncoding; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1; Up-Regulation | 2020 |
Assessment of Pregabalin-Induced Cardiotoxicity in Rats: Mechanistic Role of Angiotensin 1-7.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Biomarkers; Cardiotoxicity; Cyclic AMP-Dependent Protein Kinases; Heart Diseases; Male; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphatidylinositol 3-Kinase; Pregabalin; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Stroke Volume; Ventricular Function, Left | 2020 |
The 3' Untranslated Region Protects the Heart from Angiotensin II-Induced Cardiac Dysfunction via AGGF1 Expression.
Topics: 3' Untranslated Regions; Angiogenic Proteins; Angiotensin II; Animals; Cells, Cultured; Dependovirus; Disease Models, Animal; Genetic Therapy; Genetic Vectors; Heart Diseases; Heart Function Tests; HEK293 Cells; Humans; Male; Mice; MicroRNAs; Myeloid Cell Leukemia Sequence 1 Protein; Myocytes, Cardiac | 2020 |
FOXF1 ameliorates angiotensin II-induced cardiac fibrosis in cardiac fibroblasts through inhibiting the TGF-β1/Smad3 signaling pathway.
Topics: Angiotensin II; Animals; Cell Proliferation; Fibrosis; Forkhead Transcription Factors; Heart Diseases; Male; Myofibroblasts; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Vasoconstrictor Agents | 2020 |
Lymphangiogenic therapy prevents cardiac dysfunction by ameliorating inflammation and hypertension.
Topics: Angiotensin II; Animals; Biomarkers; Endothelial Cells; Gene Knock-In Techniques; Genome-Wide Association Study; Green Fluorescent Proteins; Heart Diseases; Homeodomain Proteins; Humans; Hypertension; Male; Mice; Mice, Inbred C57BL; Myocardium; Random Allocation; Sequence Analysis, RNA; Tumor Suppressor Proteins; Vascular Endothelial Growth Factor C | 2020 |
Nerolidol improves cardiac function in spontaneously hypertensive rats by inhibiting cardiac inflammation and remodelling associated TLR4/ NF-κB signalling cascade.
Topics: Angiotensin II; Animals; Cell Line; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Heart Diseases; Inflammation; Male; Models, Molecular; Molecular Structure; NF-kappa B; Protein Conformation; Rats, Inbred SHR; Rats, Inbred WKY; Sesquiterpenes; Toll-Like Receptor 4 | 2021 |
Tranilast prevents doxorubicin-induced myocardial hypertrophy and angiotensin II synthesis in rats.
Topics: Angiotensin II; Animals; Antioxidants; Cardiomegaly; Doxorubicin; Fibrosis; Heart Diseases; Male; Mast Cells; Myocardium; ortho-Aminobenzoates; Oxidative Stress; Rats; Rats, Wistar | 2021 |
S-nitrosylation of c-Jun N-terminal kinase mediates pressure overload-induced cardiac dysfunction and fibrosis.
Topics: Angiotensin II; Animals; Aorta; Fibroblasts; Fibrosis; Heart Diseases; Humans; Imines; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type II; Rats; Rats, Inbred SHR; Signal Transduction | 2022 |
Liquiritigenin attenuates isoprenaline‑induced myocardial fibrosis in mice through the TGF‑β1/Smad2 and AKT/ERK signaling pathways.
Topics: Angiotensin II; Animals; Apoptosis; Cell Line; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Flavanones; Heart Diseases; Heart Function Tests; Isoproterenol; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta1 | 2021 |
Pressure-overload-induced angiotensin-mediated early remodeling in mouse heart.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cells, Cultured; Disease Models, Animal; Heart Diseases; Hypertrophy; Membrane Potentials; Mice, Inbred C57BL; Myocytes, Cardiac; Patch-Clamp Techniques; Pressure; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Saralasin; Stress, Physiological | 2017 |
Inhibition of Angiotensin II-Induced Cardiac Fibrosis by Atorvastatin in Adiponectin Knockout Mice.
Topics: Adiponectin; AMP-Activated Protein Kinases; Angiotensin II; Animals; Atorvastatin; Collagen Type I; Collagen Type III; Fibrosis; Gene Expression Regulation; Gene Knockout Techniques; Heart Diseases; Injections, Subcutaneous; Male; Mice; Phosphorylation; Treatment Outcome | 2017 |
Differential Expression of Hypertensive Phenotypes in BXD Mouse Strains in Response to Angiotensin II.
Topics: Angiotensin II; Animals; Blood Pressure; Fibrosis; Heart Diseases; Hypertension; Inflammation; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred Strains; Phenotype; Species Specificity; Transforming Growth Factor beta; Vasoconstrictor Agents | 2017 |
Epac is required for exogenous and endogenous stimulation of adenosine A
Topics: Actins; Angiotensin II; Animals; Cell Differentiation; Cells, Cultured; Collagen; Cyclic AMP; Fibrosis; Guanine Nucleotide Exchange Factors; Heart Diseases; Myofibroblasts; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2B | 2018 |
Baicalin inhibits pressure overload-induced cardiac fibrosis through regulating AMPK/TGF-β/Smads signaling pathway.
Topics: Angiotensin II; Animals; Cells, Cultured; Collagen; Connective Tissue Growth Factor; Dose-Response Relationship, Drug; Fibronectins; Fibrosis; Flavonoids; Heart Diseases; Myocardium; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2018 |
CD44 Deficiency in Mice Protects the Heart Against Angiotensin Ii-Induced Cardiac Fibrosis.
Topics: Angiotensin II; Animals; Female; Fibrosis; Heart Diseases; Hyaluronan Receptors; Male; Mice; Mice, Knockout; Myocardium; NF-kappa B; Signal Transduction; Tumor Necrosis Factor-alpha | 2019 |
Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes.
Topics: Adaptation, Physiological; Angiotensin II; Animals; Blood Pressure; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Enzyme Activation; Heart Diseases; Hypertension; Male; Mice, Inbred C57BL; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Resveratrol; Signal Transduction; Time Factors; Ventricular Remodeling | 2018 |
Adopting an Orphan: How Could GRP35 Contribute to Angiotensin II-Dependent Hypertension?
Topics: Angiotensin II; Animals; Blood Pressure; Heart Diseases; Hypertension; Mice | 2018 |
Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Chronic Disease; Disease Models, Animal; Endothelial Cells; Heart Diseases; Hypoxia; Male; Mice, Inbred C57BL; Mitochondria, Heart; Myocardium; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Telmisartan | 2018 |
Irisin attenuates angiotensin II-induced cardiac fibrosis via Nrf2 mediated inhibition of ROS/ TGFβ1/Smad2/3 signaling axis.
Topics: Angiotensin II; Animals; Fibroblasts; Fibronectins; Fibrosis; Heart Diseases; Male; Mice; Mice, Inbred C57BL; Myocardium; NF-E2-Related Factor 2; Oxidative Stress; Protective Agents; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1 | 2019 |
Unique mechanistic insights into the beneficial effects of angiotensin-(1-7) on the prevention of cardiac fibrosis: A metabolomic analysis of primary cardiac fibroblasts.
Topics: Angiotensin I; Angiotensin II; Animals; Arachidonic Acid; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Differentiation; Cell Proliferation; Cells, Cultured; Fibroblasts; Fibrosis; Gas Chromatography-Mass Spectrometry; Glutathione; Heart Diseases; Male; Metabolome; Oxidative Stress; Peptide Fragments; Rats, Sprague-Dawley; Reactive Oxygen Species | 2019 |
Epigenetic modulation of tenascin C in the heart: implications on myocardial ischemia, hypertrophy and metabolism.
Topics: Angiotensin II; Animals; Cardiomegaly; Coronary Artery Disease; DNA Methylation; Energy Metabolism; Epigenesis, Genetic; Extracellular Matrix; Extracellular Matrix Proteins; Fibrosis; Heart Diseases; Humans; Hypertrophy; Hypoxia; Male; Matrix Metalloproteinase 2; MicroRNAs; Myocardial Infarction; Myocardium; Nerve Tissue Proteins; Rats; Tenascin; Ventricular Remodeling | 2019 |
A high-fat diet rich in corn oil induces cardiac fibrosis in rats by activating JAK2/STAT3 and subsequent activation of ANG II/TGF-1β/Smad3 pathway: The role of ROS and IL-6 trans-signaling.
Topics: Angiotensin II; Animals; Corn Oil; Diet, High-Fat; Fibrosis; Heart Diseases; Heart Ventricles; Humans; Interleukin-6; Janus Kinase 2; Male; Rats; Rats, Wistar; Reactive Oxygen Species; Signal Transduction; Smad3 Protein; STAT3 Transcription Factor; Transforming Growth Factor beta1 | 2019 |
Nifedipine inhibits angiotensin II-induced cardiac fibrosis via downregulating Nox4-derived ROS generation and suppressing ERK1/2, JNK signaling pathways.
Topics: Actins; Angiotensin II; Animals; Blotting, Western; Calcium Channel Blockers; Calcium Signaling; Cell Differentiation; Cell Proliferation; Cell Separation; Connective Tissue Growth Factor; Down-Regulation; Fibronectins; Fibrosis; Fluorescent Antibody Technique; Heart Diseases; In Vitro Techniques; Male; MAP Kinase Signaling System; NADPH Oxidase 4; NADPH Oxidases; Nifedipine; Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Vasoconstrictor Agents | 2013 |
Inhibition of Toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation.
Topics: Angiotensin II; Animals; Cytokines; Fibrosis; Heart Diseases; Inflammation; Inflammation Mediators; Macrophage Activation; Macrophages; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Toll-Like Receptor 2 | 2014 |
Heterozygote loss of ACE2 is sufficient to increase the susceptibility to heart disease.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Vessels; Echocardiography; Female; Genetic Predisposition to Disease; Heart; Heart Diseases; Humans; Kidney; Loss of Heterozygosity; Male; Mice; Mice, Knockout; Middle Aged; Mutation; Myocardium; Peptidyl-Dipeptidase A; Ventricular Remodeling | 2014 |
Mitochondrial NLRP3 protein induces reactive oxygen species to promote Smad protein signaling and fibrosis independent from the inflammasome.
Topics: Angiotensin II; Animals; Carrier Proteins; Collagen Type I; Fibrosis; Heart Diseases; Inflammasomes; Interleukin-18; Interleukin-1beta; Mice; Mice, Knockout; Mitochondrial Proteins; Myocardium; Myofibroblasts; NLR Family, Pyrin Domain-Containing 3 Protein; Reactive Oxygen Species; Signal Transduction; Smad Proteins, Receptor-Regulated; Transforming Growth Factor beta; Vasoconstrictor Agents | 2014 |
5TNF-α and IL-1β neutralization ameliorates angiotensin II-induced cardiac damage in male mice.
Topics: Angiotensin II; Animals; Blotting, Western; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cells, Cultured; Chemokine CCL2; Heart Diseases; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-12; Interleukin-1beta; Interleukin-6; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Receptors, Tumor Necrosis Factor, Type II; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha | 2014 |
[Protective effect of acupuncture on heart in mice with hyperlipemia and its mechanism].
Topics: Acupuncture Points; Acupuncture Therapy; Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Heart; Heart Diseases; Humans; Hyperlipidemias; Male; Mice; Mice, Inbred C57BL; Myocardium | 2014 |
Bcl10 mediates angiotensin II-induced cardiac damage and electrical remodeling.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Atrial Remodeling; B-Cell CLL-Lymphoma 10 Protein; Cell Adhesion; Cell Movement; Cells, Cultured; Disease Models, Animal; Endothelium, Vascular; Fibrosis; Heart Diseases; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Myocardium; NF-kappa B | 2014 |
Linking angiotensin II to nuclear factor-κ light chain enhancer of activated B cells-induced cardiovascular damage: bad CARMAs.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Atrial Remodeling; B-Cell CLL-Lymphoma 10 Protein; Heart Diseases | 2014 |
Role of MiR-30a in cardiomyocyte autophagy induced by Angiotensin II.
Topics: Angiotensin II; Animals; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cell Hypoxia; Heart Diseases; In Vitro Techniques; L-Lactate Dehydrogenase; MicroRNAs; Myocytes, Cardiac; Rats | 2015 |
Cytoplasmic translocation of HuR contributes to angiotensin II induced cardiac fibrosis.
Topics: Acetylcysteine; Angiotensin II; Animals; Collagen; Cytoplasm; Dose-Response Relationship, Drug; ELAV Proteins; Heart Diseases; Male; Mice; Mice, Inbred C57BL; Protein Transport; Reactive Oxygen Species; Transforming Growth Factor beta | 2015 |
Maternal High-Fat Diet Causes a Sex-Dependent Increase in AGTR2 Expression and Cardiac Dysfunction in Adult Male Rat Offspring.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomegaly; Diet, High-Fat; Female; Fetal Development; Genetic Predisposition to Disease; Heart Diseases; Imidazoles; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Pregnancy; Prenatal Exposure Delayed Effects; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Sex Characteristics | 2015 |
Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.
Topics: Adrenal Glands; Aldehydes; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Blood Pressure; Disease Models, Animal; Drug Therapy, Combination; Eplerenone; Heart Diseases; Hypertension; Lipid Peroxidation; Losartan; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Oxidative Stress; Rats, Sprague-Dawley; Renin-Angiotensin System; Signal Transduction; Spironolactone; Time Factors; Tyrosine | 2015 |
Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis.
Topics: Aging; Angiotensin II; Animals; Aorta; Blood Pressure; Body Weight; Chemokine CCL2; Diet, High-Fat; Disease Models, Animal; Endothelium, Vascular; Fibrosis; Glucagon-Like Peptide-1 Receptor; Heart; Heart Diseases; Hypertension; I-kappa B Proteins; Immunohistochemistry; Incretins; Inflammation; Interleukin-10; Liraglutide; Macrophages; Male; Mice; Mice, Inbred C57BL; Myocardium; NF-kappa B p50 Subunit; Obesity; Oxidative Stress; Real-Time Polymerase Chain Reaction; Vasoconstrictor Agents; Vimentin | 2016 |
Insulin sensitizing and cardioprotective effects of Esculetin and Telmisartan combination by attenuating Ang II mediated vascular reactivity and cardiac fibrosis.
Topics: Angiotensin II; Animals; Benzimidazoles; Benzoates; Cardiotonic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrosis; Heart Diseases; Insulin Resistance; Male; Rats; Rats, Wistar; Telmisartan; Treatment Outcome; Umbelliferones; Vasoconstriction | 2015 |
Improving vagal activity ameliorates cardiac fibrosis induced by angiotensin II: in vivo and in vitro.
Topics: Angiotensin II; Animals; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cholinesterase Inhibitors; Collagen; Constriction, Pathologic; Drug Evaluation, Preclinical; Fibroblasts; Fibrosis; Gene Knockdown Techniques; Heart Diseases; Male; Pyridostigmine Bromide; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Vagus Nerve | 2015 |
MicroRNA-503 promotes angiotensin II-induced cardiac fibrosis by targeting Apelin-13.
Topics: 3' Untranslated Regions; Adipokines; Angiotensin II; Animals; Apelin; Base Sequence; Binding Sites; Cell Proliferation; Cells, Cultured; Fibroblasts; Fibrosis; Gene Expression; Heart Diseases; Intercellular Signaling Peptides and Proteins; Male; Mice, Inbred C57BL; MicroRNAs; Myocardium; RNA Interference | 2016 |
TNF/Ang-II synergy is obligate for fibroinflammatory pathology, but not for changes in cardiorenal function.
Topics: Angiotensin II; Animals; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Fibrosis; Flow Cytometry; Heart; Heart Diseases; Inflammation; Kidney; Kidney Diseases; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Tumor Necrosis Factor, Type I; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha | 2016 |
Novel Biosensors Reveal a Shift in the Redox Paradigm From Oxidative to Reductive Stress in Heart Disease.
Topics: Angiotensin II; Antioxidants; Biosensing Techniques; Heart Diseases; Humans; Hypertension; Oxidation-Reduction; Oxidative Stress | 2016 |
Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Aorta; Collagen; Elastin; Enzyme Activation; Fibrosis; Heart Diseases; Hypertension; Immunohistochemistry; Intercellular Adhesion Molecule-1; Lipid Metabolism; Male; Neutrophil Infiltration; Oligopeptides; Oxidation-Reduction; Phosphorylation; Protein Kinase C; Rats; Rats, Sprague-Dawley; Smad2 Protein; Transforming Growth Factor beta1; Vasoconstrictor Agents | 2008 |
Does angiotensin II-aldosterone have a role in radiation-induced heart disease?
Topics: Aldosterone; Angiotensin II; Animals; Dose-Response Relationship, Radiation; Heart Diseases; Myocardium; Radiation Dosage; Radiation Injuries; Radiotherapy, Conformal; Rats; Rats, Sprague-Dawley | 2009 |
Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt.
Topics: Angiotensin II; Animals; Cytochrome P-450 CYP11B2; Enzyme Inhibitors; Fibrosis; Heart Diseases; Kidney Diseases; Mineralocorticoid Receptor Antagonists; Rats; Sodium Chloride, Dietary; Spironolactone | 2009 |
Regulatory T cells ameliorate angiotensin II-induced cardiac damage.
Topics: Adoptive Transfer; Angiotensin II; Animals; Cardiomegaly; Fibrosis; Heart Diseases; Immunosuppression Therapy; Male; Mice; Mice, Inbred Strains; T-Lymphocytes, Regulatory; Treatment Outcome | 2009 |
Excess of glucocorticoid induces cardiac dysfunction via activating angiotensin II pathway.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Atrial Natriuretic Factor; Collagen; Dexamethasone; Glucocorticoids; Heart Diseases; Hypoxia-Inducible Factor 1, alpha Subunit; Lipid Peroxidation; Male; Myocardium; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction; Superoxide Dismutase | 2009 |
ACE I/D polymorphism associated with abnormal atrial and atrioventricular conduction in lone atrial fibrillation and structural heart disease: implications for electrical remodeling.
Topics: Adult; Angiotensin II; Atrial Fibrillation; Atrioventricular Node; Case-Control Studies; Cohort Studies; Female; Heart Atria; Heart Block; Heart Diseases; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Ventricular Remodeling | 2009 |
Exaggerated blood pressure variability superimposed on hypertension aggravates cardiac remodeling in rats via angiotensin II system-mediated chronic inflammation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Chemokine CCL2; Chronic Disease; Disease Models, Animal; Heart Diseases; Heart Ventricles; Hypertension; Hypertrophy; Inflammation; Macrophages; Male; Myocytes, Cardiac; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Transforming Growth Factor beta; Ventricular Remodeling | 2009 |
Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Cells, Cultured; Disease Models, Animal; Heart Diseases; Hyperthyroidism; Hypertrophy; Imidazoles; Myocardium; Myocytes, Cardiac; Proto-Oncogene Proteins c-akt; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; Thyroxine | 2010 |
Cardiac lymphatic obstruction impairs left ventricular function and increases plasma endothelin-1 and angiotensin II in rabbits.
Topics: Angiotensin II; Animals; Endothelin-1; Female; Heart Diseases; Lymphatic Diseases; Male; Rabbits; Stroke Volume; Ventricular Dysfunction, Left | 2009 |
Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model.
Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chronic Disease; Desoxycorticosterone; Disease Models, Animal; Disease Progression; Fibrosis; Genetic Predisposition to Disease; Glomerulonephritis; Heart Diseases; Hydralazine; Hypertension; Imidazoles; Infusion Pumps, Implantable; Infusions, Subcutaneous; Kidney; Kidney Diseases; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Nephrectomy; Sodium Chloride, Dietary; Species Specificity; Telemetry; Tetrazoles; Time Factors; X-Ray Microtomography | 2010 |
Allopurinol attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction.
Topics: Allopurinol; Angiotensin II; Animals; Blood Pressure; Diastole; Electrocardiography; Enzyme Inhibitors; Fibrosis; Heart Diseases; Heart Failure, Diastolic; Heart Function Tests; Heart Rate; Male; Mice; Mice, Inbred C57BL; Myocardium; Oxidative Stress; Real-Time Polymerase Chain Reaction; RNA, Messenger; Smad Proteins; Transforming Growth Factor beta1 | 2012 |
CCR2 mediates the uptake of bone marrow-derived fibroblast precursors in angiotensin II-induced cardiac fibrosis.
Topics: Analysis of Variance; Angiotensin II; Animals; Biomarkers; Blood Pressure; Bone Marrow Cells; Cardiomegaly; Cell Movement; Disease Models, Animal; Fibroblasts; Fibrosis; Heart Diseases; Heart Rate; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Receptors, CCR2; Stem Cells; Stroke Volume; Time Factors; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2011 |
Effect of the plasminogen-plasmin system on hypertensive renal and cardiac damage.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Fibrinolysin; Fibrosis; Glomerulonephritis; Heart Diseases; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Plasminogen; Plasminogen Activator Inhibitor 1; Prevalence; Risk Factors; Tissue Plasminogen Activator | 2011 |
MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension.
Topics: Angiotensin II; Animals; Collagen Type I; Collagen Type I, alpha 1 Chain; Fibrosis; Gene Expression Regulation; Heart Diseases; Hypertension; Male; MicroRNAs; Rats; Rats, Sprague-Dawley | 2012 |
Oxidized CaMKII: a "heart stopper" for the sinus node?
Topics: Angiotensin II; Animals; Apoptosis; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Death; Electrophysiology; Heart Diseases; Heart Failure; Humans; Mice; Models, Biological; NADPH Oxidases; Oxygen; Sinoatrial Node | 2011 |
Novel mechanism of angiotensin II-induced cardiac injury in hypertensive rats: the critical role of ASK1 and VEGF.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Biphenyl Compounds; Blood Pressure; Blotting, Western; Capillaries; Cells, Cultured; Cyclic N-Oxides; Endothelial Cells; Heart Diseases; Hydralazine; Hypertension; Hypertrophy, Left Ventricular; Immunohistochemistry; Irbesartan; MAP Kinase Kinase Kinase 5; Myocardial Ischemia; Oxidative Stress; Rats; Rats, Inbred Dahl; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Spin Labels; Superoxides; Tetrazoles; Ultrasonography; Vascular Endothelial Growth Factor A | 2012 |
Candesartan cilexetil protects from cardiac myosin induced cardiotoxicity via reduction of endoplasmic reticulum stress and apoptosis in rats: involvement of ACE2-Ang (1-7)-mas axis.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autoimmune Diseases; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Cell Survival; Endoplasmic Reticulum Stress; Heart Diseases; Immunohistochemistry; In Situ Nick-End Labeling; Male; Myocarditis; Myosins; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Inbred Lew; Receptors, G-Protein-Coupled; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Signal Transduction; Tetrazoles | 2012 |
Pioglitazone ameliorates systolic and diastolic cardiac dysfunction in rat model of angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Blood Pressure; Diastole; Disease Models, Animal; Heart Diseases; Hypertension; Hypoglycemic Agents; Male; Pioglitazone; Rats; Rats, Sprague-Dawley; Systole; Thiazolidinediones | 2013 |
Angiotensin-(1-7) abrogates mitogen-stimulated proliferation of cardiac fibroblasts.
Topics: Angiotensin I; Angiotensin II; Animals; Animals, Newborn; Cell Proliferation; Cells, Cultured; Collagen; Cyclooxygenase 2; DNA; Dual Specificity Phosphatase 1; Endothelin-1; Fibroblasts; Fibrosis; Gene Expression Regulation; Heart Diseases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardium; Peptide Fragments; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Rats; Signal Transduction | 2012 |
Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.
Topics: Aldosterone; Angiotensin II; Animals; Aorta; Biomarkers; Blood Pressure; Cytochrome P-450 CYP11B2; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Heart Diseases; Inflammation; Kidney Diseases; Kidney Glomerulus; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Myocardium; Receptors, Mineralocorticoid; Renin-Angiotensin System; Sodium Chloride, Dietary; Spironolactone; Time Factors; Vascular Diseases | 2012 |
Remodeling of intrinsic cardiac neurons: effects of β-adrenergic receptor blockade in guinea pig models of chronic heart disease.
Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Angiotensin II; Animals; Cholinergic Agents; Chronic Disease; Disease Models, Animal; Evoked Potentials; Guinea Pigs; Heart; Heart Diseases; Male; Myocardial Infarction; Neurons; Receptors, Adrenergic, beta; Timolol | 2012 |
Targeting activated mineralocorticoid receptor: Occam's razor revisited.
Topics: Aldosterone; Angiotensin II; Animals; Heart Diseases; Kidney Diseases; Mineralocorticoid Receptor Antagonists; Receptors, Mineralocorticoid; Spironolactone; Vascular Diseases | 2012 |
Treatment with activated protein C (aPC) is protective during the development of myocardial fibrosis: an angiotensin II infusion model in mice.
Topics: Angiotensin II; Animals; Base Sequence; Cytokines; Disease Models, Animal; DNA Primers; Fibrosis; Fluorescent Antibody Technique; Heart Diseases; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred C57BL; Protein C; Reverse Transcriptase Polymerase Chain Reaction | 2012 |
Atrial natriuretic peptide exerts protective action against angiotensin II-induced cardiac remodeling by attenuating inflammation via endothelin-1/endothelin receptor A cascade.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Endothelin-1; Fibrillar Collagens; Fibroblasts; Fibrosis; Heart Diseases; Inflammation; Inflammation Mediators; Infusions, Intravenous; Macrophages; Male; Mitral Valve; Myocardial Contraction; Myocardium; Rats; Rats, Inbred WKY; Receptor, Endothelin A; Signal Transduction; Stroke Volume; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2013 |
Endothelin-converting enzyme inhibition ameliorates angiotensin II-induced cardiac damage.
Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Aorta; Aspartic Acid Endopeptidases; Disease Models, Animal; Echocardiography; Endothelin-1; Endothelin-Converting Enzymes; Enzyme Inhibitors; Extracellular Matrix; Fibroblast Growth Factor 2; Fibronectins; Heart Diseases; Heart Ventricles; Humans; Immunohistochemistry; Kidney; Male; Metalloendopeptidases; Prodrugs; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger | 2002 |
Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Cytochrome P-450 CYP11B2; Enzyme Inhibitors; Fibrosis; Heart Diseases; Humans; Inflammation; Kidney Diseases; Losartan; Mineralocorticoid Receptor Antagonists; Myocardium; Rats; Renin | 2005 |
Animal models of cardiac fibrosis.
Topics: Aldosterone; Angiotensin II; Animals; Disease Models, Animal; Fibroblasts; Fibrosis; Heart Diseases; Heart Ventricles; Humans; Immunohistochemistry; In Situ Hybridization; Isoproterenol; Male; Myocardial Infarction; Myocardium; Phenotype; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2005 |
Mechanisms of angiotensin II-dependent progression to heart failure.
Topics: Angiotensin II; Animals; Apoptosis; Heart Diseases; Heart Failure; Mice; Mice, Transgenic; Mitochondria; Muscle Cells; Myocardium; Promoter Regions, Genetic; Proto-Oncogene Proteins c-bcl-2; Transgenes; Up-Regulation | 2006 |
Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.
Topics: Amidohydrolases; Amlodipine; Angiotensin II; Animals; Arginine; Blood Pressure; Coronary Circulation; Coronary Vessels; Creatine Kinase, MB Form; Enzyme Activation; Enzyme Inhibitors; Fibrosis; Heart Diseases; Imidazoles; Mice; Mice, Transgenic; Myocardium; Nitric Oxide; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Peptidyl-Dipeptidase A; Pyridines; Time Factors; Tunica Media; Up-Regulation; Vasodilator Agents | 2007 |
Spotlight on renin. Mechanisms of hypertension-induced target organ damage.
Topics: Angiotensin II; Animals; Blood Vessels; Death, Sudden; Heart Diseases; Humans; Hypertension; Immune System; Kidney; Kidney Diseases; NF-kappa B; Prorenin Receptor; Receptors, Cell Surface; Renin; Renin-Angiotensin System | 2007 |
Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha.
Topics: Adenoviridae; Adiponectin; AMP-Activated Protein Kinase Kinases; Angiotensin II; Animals; Fibrosis; Heart Diseases; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinase 3; Myocardial Contraction; Myocardium; Myocytes, Cardiac; PPAR alpha; Protein Kinases; Reactive Oxygen Species; Ventricular Dysfunction, Left | 2008 |
A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation.
Topics: Angiotensin II; Animals; Apoptosis; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calmodulin; Heart Diseases; Methionine; Methionine Sulfoxide Reductases; Mice; Mutagenesis, Site-Directed; Myocytes, Cardiac; Oxidation-Reduction; Oxidoreductases; Rats; Reactive Oxygen Species; Signal Transduction | 2008 |
A possible mechanism for "tachyphylaxis' to prazosin in heart failure.
Topics: Angiotensin II; Heart Diseases; Hemodynamics; Humans; Prazosin; Quinazolines; Renin; Tachycardia | 1980 |
Perfusion pressure control by adenosine triphosphate given during cardiopulmonary bypass.
Topics: Adenosine Triphosphate; Adult; Aged; Angiotensin II; Blood Pressure; Cardiopulmonary Bypass; Coronary Artery Bypass; Endothelins; Epinephrine; Female; Heart Defects, Congenital; Heart Diseases; Heart Valve Prosthesis; Humans; Male; Middle Aged; Norepinephrine; Prostaglandins F; Thromboxane B2; Vascular Resistance; Vasodilator Agents | 1993 |
Role of the renin-angiotensin system on cardiac diseases.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Electrocardiography; Enalapril; Heart Conduction System; Heart Diseases; Humans; Renin; Renin-Angiotensin System | 1996 |
Do kinins mediate cardioprotective and renoprotective effects of cilazapril in spontaneously hypertensive rats with renal ablation?
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Cilazapril; Heart Diseases; Kidney; Kidney Diseases; Kidney Failure, Chronic; Kidney Function Tests; Kinins; Nephrectomy; Organ Size; Rats; Rats, Inbred SHR | 1995 |
Interactions between angiotensin II and nitric oxide during exercise in normal and heart failure rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Female; Heart Diseases; Heart Rate; Losartan; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Physical Conditioning, Animal; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Regional Blood Flow | 1999 |
Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes.
Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Blood Pressure; Cyclosporine; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Heart Diseases; Humans; Hypertension, Renal; Interleukin-6; Kidney; Male; Monocytes; Myocardium; Neutrophils; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Protein Binding; Rats; Renin | 2000 |
A DNA element in the alpha1 type III collagen promoter mediates a stimulatory response by angiotensin II.
Topics: Angiotensin II; Animals; Base Sequence; Cells, Cultured; Collagen; Extracellular Matrix Proteins; Fibrosis; Gene Expression; Genetic Complementation Test; Heart Diseases; Kidney Diseases; Molecular Sequence Data; Muscle Fibers, Skeletal; Mutagenesis, Site-Directed; Myocardium; Plasmids; Promoter Regions, Genetic; Proteinuria; Rats; RNA, Messenger; Transcription Factors; Transfection; Vasoconstrictor Agents | 2000 |
Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage.
Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Aspirin; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Gene Expression; Heart Diseases; Humans; I-kappa B Kinase; Kidney; Kidney Diseases; Macrophages; Monocytes; Myocarditis; Myocardium; Nephritis; NF-kappa B; Protein Serine-Threonine Kinases; Rats; Renin; Transcription Factor AP-1; Vascular Cell Adhesion Molecule-1 | 2001 |
Activation of the kallikrein-kinin system by cardiopulmonary bypass in humans.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arteries; Blood Proteins; Bradykinin; Cardiopulmonary Bypass; Carrier Proteins; Enzyme Activation; Heart Diseases; Humans; Kallidin; Kininogens; Kinins; Plasma Kallikrein; Serpins; Tissue Kallikreins; Veins | 2001 |
Effects of angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor blocker on cardiac dysfunction induced by isoproterenol in dogs.
Topics: Adrenergic beta-Agonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Creatine Kinase; Creatine Kinase, MB Form; Dogs; Female; Heart Diseases; Hemodynamics; Isoenzymes; Isoproterenol; L-Lactate Dehydrogenase; Lipid Peroxides; Male; Receptor, Angiotensin, Type 1; Ventricular Dysfunction, Left | 2001 |
Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading.
Topics: Aldosterone; Angiotensin II; Animals; Diet, Sodium-Restricted; Disease Models, Animal; Eplerenone; Heart Diseases; Male; Mineralocorticoid Receptor Antagonists; NG-Nitroarginine Methyl Ester; Potassium; Rats; Rats, Wistar; Spironolactone | 2002 |
Two ACEs and a heart.
Topics: Angiotensin II; Animals; Blood Pressure; Drosophila melanogaster; Drosophila Proteins; Gene Expression Regulation, Enzymologic; Heart; Heart Diseases; Hypertension; Metalloendopeptidases; Mice; Mice, Knockout; Myocardium; Peptidyl-Dipeptidase A; Rats; X Chromosome | 2002 |
Angiotensin II as an inflammatory mediator: evolving concepts in the role of the renin angiotensin system in the failing heart.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Heart Diseases; Inflammation Mediators; Isoquinolines; Quinapril; Rats; Renin-Angiotensin System; Tetrahydroisoquinolines | 2002 |
Diastolic compliance of the left ventricle in man.
Topics: Adolescent; Adult; Aged; Angina Pectoris; Angiotensin II; Aortic Valve Stenosis; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiac Volume; Cardiomegaly; Cineangiography; Coronary Disease; Female; Heart; Heart Diseases; Heart Function Tests; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Male; Mathematics; Middle Aged; Myocardial Contraction; Prognosis | 1975 |
Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man.
Topics: Acute Kidney Injury; Adult; Angiotensin II; Animals; Cephaloridine; Female; Heart Diseases; Humans; Kidney; Kidney Tubular Necrosis, Acute; Male; Middle Aged; Myocardial Infarction; Myocardium; Necrosis; Nephrectomy; Norepinephrine; Pyelonephritis; Rabbits; Renal Dialysis; Sodium Chloride; Urea | 1975 |
The effect of angiotensin on myocardial contractility.
Topics: Alcoholism; Angiotensin II; Animals; Blood Pressure; Cardiac Catheterization; Cardiac Output; Dogs; Heart; Heart Diseases; Heart Rate; Humans; Male; Myocardial Contraction | 1975 |
Hypertensive emergencies.
Topics: Adrenal Gland Neoplasms; Angiotensin II; Animals; Aortic Aneurysm; Aortic Dissection; Brain Diseases; Cerebrovascular Disorders; Diazoxide; Dogs; Emergencies; Female; Heart Diseases; Humans; Hydralazine; Hypertension; Methyldopa; Nitroprusside; Pheochromocytoma; Pre-Eclampsia; Pregnancy; Reserpine; Trimethaphan | 1979 |
Evidence for cardiomyopathy in familial diabetes mellitus.
Topics: Adult; Aged; Angiocardiography; Angiotensin II; Collagen; Coronary Vessels; Diabetes Complications; Diabetes Mellitus; Female; Heart Diseases; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Phospholipids; Triglycerides | 1977 |
Bartter's syndrome presenting as pseudomyocardial infarction and pseudogout.
Topics: Angiotensin II; Aspartate Aminotransferases; Bartter Syndrome; Chondrocalcinosis; Creatine Kinase; Dipyridamole; Echocardiography; Electrocardiography; Heart Diseases; Humans; Hypokalemia; Indomethacin; Magnesium Deficiency; Male; Middle Aged; Recurrence | 1992 |
Understanding your patient with cardiac disease.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Anti-Arrhythmia Agents; Antihypertensive Agents; Calcium Channel Blockers; Dental Care for Disabled; Dentist-Patient Relations; Heart Diseases; Humans; Nitrates | 1990 |
[Evaluation of hepatic venous flow patterns using a pulsed Doppler technique].
Topics: Adult; Aged; Angiotensin II; Blood Flow Velocity; Diastole; Echocardiography, Doppler; Female; Heart Diseases; Heart Function Tests; Hepatic Veins; Humans; Liver Circulation; Male; Middle Aged; Systole | 1990 |
[Left ventricular pressure-volume diagram determined by forward and backward formatting of radionuclide ventriculography and analog pressure data].
Topics: Angiotensin II; Cardiac Volume; Electrocardiography; Heart; Heart Diseases; Heart Ventricles; Humans; Middle Aged; Tomography, Emission-Computed | 1989 |
Ventricular function in noncardiacs with alcoholic fatty liver: role of ethanol in the production of cardiomyopathy.
Topics: Adult; Alcoholism; Angiotensin II; Blood Circulation; Blood Pressure; Carbohydrate Metabolism; Ethanol; Fatty Acids, Nonesterified; Fatty Liver; Heart; Heart Diseases; Heart Rate; Heart Ventricles; Humans; Male; Phosphates; Potassium; Transaminases; Triglycerides; Urine | 1969 |
[Diagnostic significance of the angiotensin infusion test].
Topics: Adolescent; Adult; Aged; Angiotensin II; Child; Diabetic Nephropathies; Female; Glomerulonephritis; Heart Diseases; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Infusions, Parenteral; Liver Cirrhosis; Male; Metaraminol; Middle Aged; Nephritis | 1968 |
Transitory primary aldosteronism-like condition.
Topics: Aged; Angiotensin II; Chlorides; Diuretics; Female; Heart Diseases; Humans; Hydrochlorothiazide; Hyperaldosteronism; Hypertension; Hypertonic Solutions; Potassium; Renin; Sodium; Sodium Chloride; Vomiting; Water-Electrolyte Balance | 1968 |
[Dynamics and contractility of the left ventricle].
Topics: Adolescent; Adult; Angiotensin II; Animals; Cardiac Catheterization; Cardiac Output; Cardiac Volume; Dogs; Electrocardiography; Female; Heart Diseases; Heart Function Tests; Heart Rate; Heart Septal Defects, Ventricular; Heart Ventricles; Humans; Male; Manometry; Middle Aged; Muscle Contraction; Norepinephrine; Ouabain; Papillary Muscles; Pentobarbital; Propranolol; Time Factors; Ventricular Function | 1969 |
Heart tone.
Topics: Angiotensin II; Animals; Endotoxins; Heart; Heart Diseases; Heart Function Tests; Humans; Isoproterenol; Norepinephrine; Pacemaker, Artificial; Propranolol | 1970 |
[Clinical considerations and hemodynamic studies in some cases of dynamic hypertrophic stenosis of the left ventricle].
Topics: Adolescent; Adult; Angiotensin II; Blood Pressure; Butylamines; Cardiac Catheterization; Cardiomegaly; Electrocardiography; Epinephrine; Female; Heart; Heart Diseases; Heart Ventricles; Hemodynamics; Humans; Kinetocardiography; Male; Middle Aged; Nitrites; Norepinephrine; Phonocardiography; Radiography, Thoracic; Strophanthins; Sympatholytics | 1970 |
[On hemodynamic control of renal function].
Topics: Angiotensin II; Diuresis; Heart Diseases; Hemodynamics; Hepatitis; Humans; Hypertension; Kidney; Kidney Function Tests | 1970 |
[Therapeutic action of digitalis and substances with analogous action. Lecture 3].
Topics: Angiotensin II; Arrhythmias, Cardiac; Blood Circulation; Blood Pressure; Cardiac Glycosides; Coronary Vessels; Digitalis Glycosides; Diuresis; Heart Conduction System; Heart Diseases; Heart Rate; Hemodynamics; Humans; Kidney; Renin | 1971 |
[Nuclear medicine in the diagnosis of heart diseases].
Topics: Angiography; Angiotensin II; Digitalis Glycosides; Heart Diseases; Humans; Krypton; Lung Diseases; Molybdenum; Myocardial Infarction; Potassium Isotopes; Radioisotope Dilution Technique; Radioisotopes; Radionuclide Imaging; Serum Albumin, Radio-Iodinated; Technetium | 1971 |
Effects of isometric exercise on cardiac performance. The grip test.
Topics: Adult; Aged; Angiotensin II; Biomechanical Phenomena; Cardiac Catheterization; Female; Hand; Heart Diseases; Heart Function Tests; Heart Ventricles; Hemodynamics; Humans; Male; Methods; Middle Aged; Muscle Contraction; Myocardium; Oxygen Consumption | 1971 |
Comparison of isometric exercise and angiotensin infusion as stress test for evaluation of left ventricular function.
Topics: Angiotensin II; Arteriosclerosis; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiomyopathies; Coronary Disease; Evaluation Studies as Topic; Heart; Heart Diseases; Heart Rate; Humans; Myocardium; Oxygen Consumption; Physical Exertion; Stress, Physiological | 1973 |
Plasma renin and angiotensin II levels in subarachnoid haemorrhage.
Topics: Adult; Angiotensin II; Blood Pressure; Cerebral Angiography; Consciousness Disorders; Electrocardiography; Epinephrine; Female; Heart Diseases; Humans; Intracranial Aneurysm; Middle Aged; Normetanephrine; Renin; Sodium; Subarachnoid Hemorrhage | 1974 |